These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 19968075

  • 1. [Frequency of factor VIII inhibitor in the patients with hemophilia A and environmental risk factors for inhibitor development].
    Yan ZY, Fan LK, Li KX, Wang XY, Hua BL, Wang SJ, Zhao YQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):580-3. PubMed ID: 19968075
    [Abstract] [Full Text] [Related]

  • 2. [Screening and analysis of coagulation factor VIII inhibitor in patients with hemophilia A].
    Zhang AL, Yang LH, Liu XE, Zhao H, Zhang JH, Dong CX, Qi XL, Qin XY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):968-70. PubMed ID: 21867625
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A].
    Fan LK, Wang ZW, Hua BL, Su W, Wang SJ, Zhao YQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):551-4. PubMed ID: 19968068
    [Abstract] [Full Text] [Related]

  • 4. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M, Kumari M, Shamsi T, Naz A, Farzana T.
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [Abstract] [Full Text] [Related]

  • 5. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
    Mariani G, Kroner B, Immune Tolerance Study Group (ITSG).
    Haematologica; 2001 Nov; 86(11):1186-93. PubMed ID: 11694405
    [Abstract] [Full Text] [Related]

  • 6. Risk of inhibitor development in mild haemophilia A increases with age.
    Mauser-Bunschoten EP, Den Uijl IE, Schutgens RE, Roosendaal G, Fischer K.
    Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients.
    Luna-Záizar H, Esparza-Flores MA, López-Guido B, Aguilar-López LB, Cortés Alvarez CR, Jaloma-Cruz AR.
    Int J Lab Hematol; 2009 Dec; 31(6):673-82. PubMed ID: 18771497
    [Abstract] [Full Text] [Related]

  • 9. [A cross-sectional survey of coagulation factor VIII inhibitor in children with hemophilia A].
    Wei Q, Li G, Tang L, Chen Z, Zhen Y, Wu X, Zhang N, Zhang J, Yu G, Wu R.
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):99-102. PubMed ID: 24739719
    [Abstract] [Full Text] [Related]

  • 10. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
    Kreuz W, Becker S, Lenz E, Martinez-Saguer I, Escuriola-Ettingshausen C, Funk M, Ehrenforth S, Auerswald G, Kornhuber B.
    Semin Thromb Hemost; 1995 Feb; 21(4):382-9. PubMed ID: 8747701
    [Abstract] [Full Text] [Related]

  • 11. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.
    von Auer Ch, Oldenburg J, von Depka M, Escuriola-Ettinghausen C, Kurnik K, Lenk H, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1051():498-505. PubMed ID: 16126990
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of FVIII Inhibitors Among Children with Hemophilia A: Experience at the Jordanian Royal Medical Services.
    Oudat R, Al-Maharmeh M, Al-Ghrayeb R, Ogeilat T, Mustafa MK.
    Med Arch; 2020 Jun; 74(3):187-190. PubMed ID: 32801433
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
    Sherief LM, Gaber OA, Youssef HM, Sherbiny HS, Mokhtar WA, Ali AAA, Kamal NM, Abdel Maksoud YH.
    Ital J Pediatr; 2020 Sep 14; 46(1):129. PubMed ID: 32928254
    [Abstract] [Full Text] [Related]

  • 14. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F.
    Acta Haematol; 2005 Sep 14; 114(2):84-90. PubMed ID: 16103630
    [Abstract] [Full Text] [Related]

  • 15. Recombinant factor concentrates may increase inhibitor development: a single centre cohort study.
    Strauss T, Lubetsky A, Ravid B, Bashari D, Luboshitz J, Lalezari S, Misgav M, Martinowitz U, Kenet G.
    Haemophilia; 2011 Jul 14; 17(4):625-9. PubMed ID: 21299743
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 Jul 14; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J, Gómez E, Rendal E, Torea J, Lourés E, Couselo M, Vila P, Sedano C, Tusell X, Magallón M, Quintana M, González-Boullosa R, López-Fernández MF.
    Ann Hematol; 1996 May 14; 72(5):321-6. PubMed ID: 8645745
    [Abstract] [Full Text] [Related]

  • 18. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun 14; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 19. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.
    Holstein K, Marx G, Lentz B, Bokemeyer C, Langer F.
    Hamostaseologie; 2012 Jun 14; 32 Suppl 1():S48-51. PubMed ID: 22960877
    [Abstract] [Full Text] [Related]

  • 20. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L, Pitlik E.
    Haematologica; 2000 Oct 14; 85(10 Suppl):64-8. PubMed ID: 11187874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.